(Q48371805)

11 February 2018

title

Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia (English)

1 reference

11 February 2018

author name string

A G Lam

1

1 reference

11 February 2018

M A Soriano

2

1 reference

11 February 2018

J A Monn

3

1 reference

11 February 2018

D D Schoepp

4

1 reference

11 February 2018

D Lodge

5

1 reference

11 February 2018

J McCulloch

6

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

11 February 2018

number of pages

3

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

11 February 2018

volume

254

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

121-123

1 reference

11 February 2018

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

A novel orally active group 2 metabotropic glutamate receptor agonist: LY354740.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

Activation of the metabotropic glutamate receptor is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxioly

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

The metabotropic glutamate receptors: structure and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900651-X

7 January 2021

10.1016/S0304-3940(98)00651-X

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018